CRISPR Journal
Scope & Guideline
Exploring the Frontiers of CRISPR Technology
Introduction
Aims and Scopes
- Genome Editing Techniques and Innovations:
The journal extensively covers novel advancements in CRISPR-based genome editing techniques, including Cas9, Cas12, and base editing, focusing on their mechanisms, efficiency, and applications in various organisms. - Clinical Applications and Therapeutics:
Research on the translation of CRISPR technologies into clinical settings is a significant focus area, including studies on gene therapies for genetic disorders, cancer treatment, and potential applications in regenerative medicine. - Ethics and Policy in Genome Editing:
The journal addresses the ethical implications and regulatory considerations surrounding CRISPR technologies, particularly in the context of human germline editing and the societal impacts of genome editing. - Synthetic Biology and CRISPR Integration:
There is a growing emphasis on the integration of CRISPR with synthetic biology, exploring how these technologies can be used to engineer biological systems for various applications, including agriculture and environmental science. - Off-Target Effects and Safety Assessments:
The journal highlights research addressing the safety and precision of CRISPR editing, including studies on off-target effects, evaluation methodologies, and improvements in targeting accuracy.
Trending and Emerging
- Prime Editing and Next-Generation Editing Technologies:
Prime editing has gained significant attention as a next-generation genome-editing technique, with recent publications exploring its potential advantages over traditional CRISPR methods, including increased precision and reduced off-target effects. - CRISPR in Clinical Trials and Therapeutics:
There is a marked increase in research related to the transition of CRISPR technologies into clinical trials, emphasizing the therapeutic potential of genome editing for treating genetic disorders and cancers. - Artificial Intelligence in CRISPR Research:
The intersection of AI and CRISPR technology is emerging as a vital theme, with papers focusing on how machine learning can enhance CRISPR design, predict outcomes, and optimize editing strategies. - Ethical Considerations of Gene Editing:
With the rapid advancements in CRISPR technology, discussions around the ethical implications of genome editing, particularly in human applications, have become increasingly prominent in the journal. - CRISPR Applications Beyond Gene Editing:
Research exploring CRISPR applications in diagnostics, biosensing, and synthetic biology is on the rise, indicating a shift towards broader uses of CRISPR technologies beyond traditional gene editing.
Declining or Waning
- Basic Mechanistic Studies of CRISPR Systems:
There has been a noticeable decline in publications focusing solely on the basic biological mechanisms of CRISPR systems, as the field shifts towards applied research and clinical applications. - Agricultural Applications of CRISPR:
Although still relevant, the frequency of studies specifically targeting agricultural improvements through CRISPR has diminished, likely due to a growing emphasis on human health applications and clinical research. - Historical and Philosophical Perspectives on CRISPR:
Papers discussing the historical development and philosophical implications of CRISPR technologies have become less common as the journal prioritizes empirical research and immediate applications. - Single-Organism Studies:
Research focusing exclusively on CRISPR applications in single organisms, particularly non-model organisms, has decreased as the community increasingly values studies with broader implications across multiple species. - Regulatory Frameworks for Non-Human Editing:
The focus on regulatory considerations for non-human CRISPR applications, such as in environmental or agricultural contexts, has waned, possibly overshadowed by the urgency of human health applications.
Similar Journals
Molecular Therapy Nucleic Acids
Pioneering the next generation of nucleic acid therapies.Molecular Therapy Nucleic Acids is a premier open-access journal published by CELL PRESS, dedicated to advancing the field of molecular medicine through the innovative application of nucleic acid-based therapies. Since its inception in 2012, this journal has become an essential resource for researchers and professionals in drug discovery and molecular medicine, reflected in its status as a Q1 journal in both categories for 2023. With a notable impact factor and high rankings in Scopus, including #8 out of 157 in Drug Discovery and #16 out of 178 in Molecular Medicine, it serves to disseminate groundbreaking research and foster collaborations among scientists worldwide. The journal's comprehensive scope encompasses a wide variety of topics, including gene therapy, RNA interference, and CRISPR technology, ensuring that it remains at the forefront of scientific excellence. With open access availability, Molecular Therapy Nucleic Acids actively promotes the widespread dissemination of knowledge, making its crucial insights accessible to students, researchers, and industry professionals alike.
BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT
Leading the Charge in Open Access Biotechnology ResearchBIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT is a leading open access journal published by TAYLOR & FRANCIS LTD from the United Kingdom, dedicated to advancing the field of biotechnology since its inception in 1990. Committed to disseminating high-quality research, the journal has transitioned to open access since 2014, enhancing its accessibility for researchers, professionals, and students alike. With a notable impact in the field, it is categorized in the Q3 quartile for Biotechnology as of 2023 and ranks #193 out of 311 in the Scopus categories for Biochemistry, Genetics, and Molecular Biology. The journal aims to cover a diverse range of topics related to both biotechnological advancements and the equipment that supports them, thus fostering innovative research and practical applications in the biotechnology sector. With an evolving scope that reflects the dynamic nature of biological research, BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT plays a crucial role in bridging the gap between laboratory studies and real-world applications, making it an essential resource for anyone involved in biotechnology research.
Journal of Genetic Engineering and Biotechnology
Connecting Theory and Practice in Genetic EngineeringJournal of Genetic Engineering and Biotechnology, published by Elsevier Science Inc, is a prestigious open-access journal that stands at the forefront of research in the fields of biotechnology and genetics. Since its inception in 2011, the journal has provided a platform for cutting-edge studies that explore the complexities and innovations within genetic engineering and its applications in biotechnology. With a commendable Impact Factor and recognized as a Q2 journal in both biotechnology and genetics as per 2023 categorization, it ranks well within Scopus, evidencing its influence in the scientific community. Researchers and professionals accessing articles published in this journal benefit from timely contributions that bridge theoretical and practical aspects of genetic technologies. By fostering a collaborative environment, the Journal of Genetic Engineering and Biotechnology aims to promote advancements that drive science forward, making it an essential resource for students, academics, and industry practitioners alike. For those interested in making their mark in these rapidly evolving fields, this journal offers unparalleled access to high-quality, peer-reviewed research.
TRANSGENIC RESEARCH
Catalyzing Breakthroughs in Agronomy and Animal ScienceTRANSGENIC RESEARCH, an esteemed academic journal published by Springer, has been at the forefront of the fields of agronomy, animal science, and biotechnology since its inception in 1991. With an ISSN of 0962-8819 and an E-ISSN of 1573-9368, this journal is pivotal in disseminating cutting-edge research and innovative methodologies that pave the way for advancements in genetic engineering and transgenic technology. Ranked in the Q2 category for Agronomy and Crop Science, Animal Science and Zoology, and Biotechnology, and within the top 90th percentile in Scopus for several related categories, TRANSGENIC RESEARCH maintains a prominent position in the global scientific community. This journal serves as a vital resource for researchers, professionals, and students, providing a platform for papers that explore both fundamental and applied aspects of transgenic research, ultimately contributing to sustainable agricultural practices and environmental stewardship. The journal’s commitment to fostering dialogue and collaboration among experts makes it an essential read for anyone interested in pushing the boundaries of genetic research.
Cell Stem Cell
Transforming Knowledge into Innovation in Stem Cell ScienceCell Stem Cell, published by CELL PRESS, is a premier journal at the forefront of cellular biology, genetics, and molecular medicine. With an esteemed impact factor and recognized as a Q1 journal in multiple categories including Cell Biology, Genetics, and Molecular Medicine, it offers researchers, professionals, and students rigorous, peer-reviewed articles that shape the future of stem cell research and regenerative medicine. Located in Cambridge, MA, this journal has become an invaluable resource since its inception in 2007 and is committed to disseminating groundbreaking findings that drive innovation and understanding in these critical fields. By consistently ranking within the top percentile of its categories in Scopus, Cell Stem Cell remains an essential platform for scholarly communication, fostering collaboration among leading scientists worldwide. Although the journal does not currently offer open access options, its comprehensive insights are pivotal for anyone engaged in the study of stem cells and their applications.
BMB Reports
Advancing the Frontiers of Biochemistry and Molecular BiologyBMB Reports is a distinguished open-access journal published by the Korean Society of Biochemistry & Molecular Biology since 2008, making significant contributions to the fields of biochemistry, molecular biology, and medicine. With a current impact factor that positions it in the Q2 category for Biochemistry and Q1 for Miscellaneous Medicine, this journal supports a wide dissemination of high-quality research findings, fostering robust dialogue among researchers, professionals, and students alike. Based in Seoul, South Korea, BMB Reports aims to publish innovative studies that advance our understanding of biochemical and molecular processes, thus shaping the future of health and medicine. The journal's commitment to open access enhances the visibility of its articles, allowing for greater accessibility and engagement in the scientific community. With notable rankings in both the Biochemistry and Molecular Biology categories, BMB Reports stands as a vital resource for those seeking to stay at the forefront of research in these rapidly evolving disciplines.
Cells, published by MDPI in Switzerland, is a leading open-access journal that has been disseminating groundbreaking research in the fields of Biochemistry, Genetics, and Molecular Biology since its inception in 2011. With an impressive E-ISSN of 2073-4409, the journal boasts a strong impact factor and ranks in the 84th percentile for Scopus ratings, underscoring its significance in advancing scientific knowledge. As a Q1-ranked journal in both 2023 and 2020, it serves as a premier platform for researchers, professionals, and students eager to explore innovative findings and methodologies. By providing unrestricted access to high-quality research, Cells plays a pivotal role in facilitating collaboration and inspiration within the global scientific community, making it an indispensable resource for anyone interested in cutting-edge discoveries in cellular biology.
EXPERIMENTAL ANIMALS
Exploring the frontiers of experimental animal research.EXPERIMENTAL ANIMALS is a leading journal that serves the vibrant fields of Animal Science, Veterinary Medicine, and Biochemistry, Genetics, and Molecular Biology, published by the prestigious INT PRESS EDITING CENTRE INC in Japan. Boasting an impressive track record since its inception in 1974, the journal has positioned itself as a crucial platform for researchers aiming to disseminate innovative findings in experimental animal research. With a commendable impact factor and categorized in the Q2 and Q3 quartiles by Scopus in various relevant fields for 2023, EXPERIMENTAL ANIMALS exemplifies excellence in its contributions to science. The journal offers a comprehensive range of articles spanning from animal welfare and experimental methodologies to genetic studies, ensuring a multidisciplinary approach that appeals to a diverse audience of researchers, professionals, and students. Access to its wealth of knowledge fosters significant advancements in research and practice, underlining the journal's commitment to enhancing understanding of animal models in scientific inquiry.
Cellular Reprogramming
Advancing the Future of Cellular TherapiesCellular Reprogramming is a prominent academic journal published by MARY ANN LIEBERT, INC, dedicated to advancing the field of cellular biology and biotechnology. With its ISSN 2152-4971 and E-ISSN 2152-4998, this journal provides an innovative platform for researchers and professionals to share groundbreaking research findings on cellular reprogramming, stem cell biology, and regenerative medicine. Established in 2010, and actively publishing until 2024, the journal is recognized for its contributions, evidenced by its categorizations in the Q3 and Q4 quartiles across several related fields, including biotechnology and developmental biology. This peer-reviewed journal not only supports open access to scientific literature but also aims to enhance interdisciplinary collaboration among scientists. With a growing impact in the realms of biochemistry, genetics, and molecular biology, Cellular Reprogramming remains an essential resource for the dissemination of pioneering research that could shape the future of cellular therapies.
Horticulture Research
Bridging theory and practice in horticultural excellence.Horticulture Research, published by Oxford University Press Inc, is a leading open-access journal dedicated to advancing knowledge in the fields of horticulture, plant science, and related biotechnological disciplines. Since its inception in 2014, the journal has rapidly established itself as a premier outlet for research, boasting prestigious Q1 rankings across multiple categories including Biochemistry, Biotechnology, Genetics, Horticulture, and Plant Science in 2023. With exceptional Scopus rankings—placing it in the top 2% of Horticulture journals and 4% for Plant Science globally—Horticulture Research provides a vital platform for scholars, professionals, and students to disseminate and engage with innovative findings. Emphasizing the importance of open accessibility, the journal allows for widespread dissemination of impactful research, making it an invaluable resource for those striving to enhance sustainable horticultural practices and plant-based innovations. Its aim to bridge the gap between theoretical study and practical application reflects the dynamic nature of the horticultural sciences today.